Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021

SELL
$10.82 - $19.37 $49,739 - $89,043
-4,597 Closed
0 $0
Q1 2021

Apr 26, 2021

SELL
$7.02 - $22.62 $304,513 - $981,210
-43,378 Reduced 90.42%
4,597 $88,000
Q4 2018

Jan 31, 2019

SELL
$3.02 - $9.2 $43,759 - $133,308
-14,490 Reduced 23.2%
47,975 $160,000
Q1 2018

May 09, 2018

BUY
$4.02 - $6.81 $68,319 - $115,735
16,995 Added 37.38%
62,465 $0
Q4 2017

Feb 07, 2018

SELL
$2.89 - $3.76 $42,436 - $55,211
-14,684 Reduced 24.41%
45,470 $0
Q3 2017

Nov 13, 2017

BUY
$2.02 - $4.05 $121,511 - $243,623
60,154
60,154 $0

Others Institutions Holding AMRS

About AMYRIS, INC.


  • Ticker AMRS
  • Exchange NASDAQ
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 324,860,000
  • Market Cap $3.25M
  • Description
  • Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...
More about AMRS
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.